Zu "1414386-05-2" wurden 2 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
NEU
Anti-IL-17A/F and Serum Albumin Nanobody (Sonelokimab)
Anti-IL-17A/F and Serum Albumin Nanobody (Sonelokimab)

Artikelnummer: BPS-84254-1

Sonelokimab, also known as ALX 076,1 is a trivalent bispecific nanobody composed of camel derived humanized IL-17 F antibodies, IL-17A/F antibodies, and serum albumin VHH antibodies. Sonelokimab can prolong the plasma half-life by binding to human serum albumin. Sonelokimab can be used for research on rheumatoid...
Schlagworte: IL17A, Interleukin-17A, Cytotoxic T-lymphocyte-associated antigen 8
Anwendung: ELISA, FC, FA
Wirt: Human
CAS 1414386-05-2
ab 1.646,00 €
Bewerten
Sonelokimab
Sonelokimab

Artikelnummer: TGM-T76885-5mg

Description: Sonelokimab (ALX 0761, M 1095) is a trivalent nanobody combining monovalent camelid-derived nanobodies targeting human interleukin (IL)-17A and IL-17F with human serum albumin VHHs, presenting it as a promising candidate for investigating plaque-type psoriasis treatments [1] [2].
CAS 1414386-05-2
1.308,00 €
Bewerten